Jianfeng Li Selected Research

DNA (Deoxyribonucleic Acid)

8/2022	Molecular mechanism of anionic stabilizer for telomere G-quadruplex.
1/2021	Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists.
1/2021	Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.
1/2017	FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage.
1/2015	Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system.
7/2013	Tumor targeting and microenvironment-responsive nanoparticles for gene delivery.
6/2013	Base excision repair facilitates a functional relationship between Guanine oxidation and histone demethylation.
10/2011	Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
8/2011	[Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer].
3/2011	Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianfeng Li Research Topics

Disease

71	Neoplasms (Cancer) 01/2024 - 06/2005
20	Glioma (Gliomas) 01/2024 - 01/2007
16	Ototoxicity 04/2024 - 06/2016
11	Inflammation (Inflammations) 05/2023 - 01/2013
11	Hearing Loss (Hearing Impairment) 10/2019 - 11/2011
10	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2002
9	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 04/2008
8	Congenital Abnormalities (Deformity) 06/2023 - 01/2018
8	Carcinoma (Carcinomatosis) 01/2021 - 04/2008
6	Lung Neoplasms (Lung Cancer) 05/2023 - 04/2005
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2011
6	Brain Neoplasms (Brain Tumor) 01/2021 - 08/2011
5	Melanoma (Melanoma, Malignant) 01/2024 - 06/2005
5	Hemorrhage 06/2023 - 04/2012
5	Glioblastoma (Glioblastoma Multiforme) 07/2022 - 12/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 06/2005
4	Stroke (Strokes) 04/2024 - 10/2003
4	Facial Paralysis (Facial Palsy) 12/2019 - 04/2012
4	Breast Neoplasms (Breast Cancer) 10/2019 - 03/2015
4	Sensorineural Hearing Loss 10/2019 - 01/2016
4	Necrosis 05/2019 - 04/2007
3	Shock 04/2024 - 03/2019
3	Thrombosis (Thrombus) 02/2024 - 06/2023
3	Atherosclerosis 01/2023 - 03/2004
3	Pain (Aches) 01/2023 - 11/2017
3	Wounds and Injuries (Trauma) 12/2022 - 12/2011
3	Infections 04/2022 - 07/2010
3	Hypertension (High Blood Pressure) 09/2021 - 03/2004
3	Erectile Dysfunction 01/2019 - 06/2005
3	Long QT Syndrome 11/2018 - 04/2003
3	Catalepsy 02/2018 - 01/2016
3	Weight Gain 01/2018 - 01/2016
3	Migraine Disorders (Migraine) 11/2017 - 05/2011
3	Metaplasia 01/2016 - 01/2013
3	Sneezing 01/2016 - 01/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2012 - 10/2003
2	Ischemic Stroke 04/2024 - 09/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2024
2	Otomycosis 12/2023 - 04/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2023 - 01/2017
2	Cerebral Infarction 01/2023 - 11/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

16	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 01/2017
16	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2015
10	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 03/2011
10	LigandsIBA 01/2022 - 02/2011
7	EnzymesIBA 04/2024 - 08/2011
7	MicellesIBA 08/2019 - 10/2012
7	Peptides (Polypeptides)IBA 02/2016 - 07/2010
6	CytokinesIBA 01/2024 - 04/2008
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 02/2011
5	Circular RNAIBA 04/2024 - 01/2021
5	AnticoagulantsIBA 02/2024 - 01/2023
5	Long Noncoding RNAIBA 01/2023 - 11/2018
5	Messenger RNA (mRNA)IBA 01/2023 - 06/2005
5	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2022 - 10/2007
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 07/2010
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018 - 12/2003
5	Dendrimers (Dendrons)IBA 01/2016 - 02/2011
4	HydrogelsIBA 05/2024 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2019
4	Temozolomide (Temodar)FDA LinkGeneric 07/2022 - 10/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2007
4	Small Interfering RNA (siRNA)IBA 11/2015 - 12/2012
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2015 - 02/2011
3	LipidsIBA 02/2024 - 01/2017
3	AntigensIBA 01/2024 - 06/2005
3	Polyvinyl Chloride (PVC)IBA 11/2023 - 01/2022
3	Lysine (L-Lysine)FDA Link 06/2023 - 10/2013
3	pembrolizumabIBA 03/2023 - 06/2019
3	Competitive Endogenous RNAIBA 01/2023 - 11/2020
3	GraphiteIBA 08/2021 - 08/2019
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2010
3	Therapeutic UsesIBA 11/2020 - 04/2008
3	Phosphodiesterase 5 InhibitorsIBA 01/2019 - 06/2005
3	Phencyclidine (Angel Dust)IBA 02/2018 - 01/2016
3	Pattern Recognition ReceptorsIBA 01/2017 - 07/2010
3	OvalbuminIBA 01/2016 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2008
3	Transferrin Receptors (Transferrin Receptor)IBA 01/2016 - 02/2011
3	Immunoglobulin E (IgE)IBA 01/2016 - 01/2013
3	Poly(amidoamine)IBA 01/2016 - 02/2011
3	Choline (Choline Chloride)IBA 09/2015 - 01/2013
3	Contrast MediaIBA 01/2013 - 04/2011
3	Peroxynitrous Acid (Peroxynitrite)IBA 11/2011 - 10/2003
2	Heparin (Liquaemin)FDA LinkGeneric 02/2024 - 06/2023
2	Terbinafine (Lamisil)FDA LinkGeneric 12/2023 - 04/2020
2	Immunologic Factors (Immunomodulators)IBA 05/2023 - 10/2007
2	AntithrombinsIBA 01/2023 - 01/2023
2	AcidsIBA 01/2023 - 01/2013
2	Factor Xa InhibitorsIBA 01/2023 - 01/2023

Therapy/Procedure

34	Therapeutics 01/2024 - 02/2011
16	Drug Therapy (Chemotherapy) 11/2022 - 03/2010
8	External Fixators 06/2023 - 01/2018
4	Immunotherapy 01/2024 - 10/2007
4	Sympathectomy (Sympathectomies) 11/2018 - 04/2003
4	Thoracotomy 01/2017 - 11/2002
3	Intravenous Administration 01/2015 - 03/2011
2	Sutures (Suture) 01/2023 - 04/2018